- Building Your Portfolio on Homebuilding Stocks

- Pisani: New ETF = Play on Mid-East Growth

- Play the Coming Power-Grid Upgrade

- Essential Oils For Your Portfolio

- Building a Portfolio With Pulte (!)

- Video: DON'T Sell Stocks Now!

- Options Action: Moving on BJ's, Wells Fargo, Coal

- Winning Micro Cap Energy Stocks

- Tattoo-Removal Stocks: Buy the 'Tidal Wave'

- Earnings & Stocks: The Energy, Bank Switcheroo
- Building Your Portfolio on Homebuilding Stocks
- Stop Trading!: A War on Wall Street
- Pisani: New ETF = Play on Mid-East Growth
- Existing Home Sales: A Look At Numbers That Weren't There
- Comicon: Not Just Funny Business
- See What People Are Saying About... Water Scarcity
- Microsoft's Ballmer Addresses Analysts
- Fast Money: Wall Street Got Drunk!
- Play the Coming Power-Grid Upgrade
- Microsoft's Johnson: What His Leaving Means For Company
- Crocs Shares Tank as Shomaker Slashes Outlook
- WaMu Shares Get Slammed as Credit Worries Grow
- Best Trades Now: Tech, Utilities, Financials & More
- Gassing Up With Garbage
- UBS Target of Fraud Suit from NY Attorney General
- SEC Plans to Broaden Curbs on Short Sales: Cox
- 30-Year Bond Gains Full Point as Stocks Weaken
- FCC Agrees to Approve Sirius Pruchase of XM: Report
- Union Pacific Profit Rises, Beats Estimates
Will Muggia likes biotech. Muggia's Touchstone Mid-Cap Growth Fund is up an average of 14.9 percent annually over the last three years -- and even this year, it's up 1.8 percent. So what are the 4-star portfolio manager's picks?
Recommendations:
Muggia likes Celgene [CELG
Loading...
()
], "one of the fastest-growing biotechnology companies in the world today. He expects the firm to have 40 percent earnings growth.
He praises Elan Pharmaceuticals [ELAN
Loading...
()
] for its auto-immune and Alzheimer's medicines. He says the latter illness has barely begun to be addressed medically, with plenty of potential left.
CNBC.com Web Exclusive:
(Not found on TV)
For CNBC.com readers, Muggia also recommends Chesapeake Energy [CHK
Loading...
()
].
Disclosures:
Muggia personally owns both Celgene and Elan, and the stocks are the largest holdings in his fund.





